igf 1 lr3 blue sky LONG® R³ IGF-I IGF-1 LR3: muscle growth, or

The approval is supported by data from the Phase III NRG-GY018/ KEYNOTE-868 trial, in which the regimen reduced the risk of disease progression or death by 40% in patients whose cancer was mismatch repair proficient and by 70% in patients whose cancer was mismatch repair deficient, when compared to placebo with carboplatin and paclitaxel followed by placebo alone

Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin

Arachidonic acid- (AA-) containing phosphatidylethanolamine (PE) and adrenic acid- (AdA-) containing PE were previously identified as the primary substrates for lipid peroxidation (Kagan et al., 2020), but mounting evidence raises doubts about this mechanism since a range of polyunsaturated fatty acids (PUFAs) may be implicated in ferroptosis (Zheng and Conrad, 2020)

10.1016/j.ejcb.2013.11.005 (2014)

Inhalation treatment with glutathione in patients with cystic fibrosis: a randomized clinical trial